Format

Send to

Choose Destination
Tissue Eng Part C Methods. 2017 Jul;23(7):412-421. doi: 10.1089/ten.TEC.2017.0118. Epub 2017 Jun 23.

The Magnetic Field of Magnetic Resonance Imaging Systems Does Not Affect Cells Labeled with Micrometer-Sized Iron Oxide Particles.

Author information

1
1 Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Experimental Surgery and Regenerative Medicine, Charité - Universitätsmedizin Berlin , Berlin, Germany .
2
2 Department of Diagnostic and Interventional Radiology, Charité - Universitätsmedizin Berlin , Campus Virchow-Klinikum, Berlin, Germany .
3
3 Microparticles GmbH, Berlin, Germany .
4
4 BIH Charité Clinician Scientist Program, Berlin Institute of Health (BIH) , Berlin, Germany .

Abstract

INTRODUCTION:

Labeling using iron oxide particles enables cell tracking through magnetic resonance imaging (MRI). However, the magnetic field can affect the particle-labeled cells. Here, we investigated the effects of a clinical MRI system on primary human hepatocytes labeled using micrometer-sized iron oxide particles (MPIOs).

METHODS:

HuH7 tumor cells were incubated with increasing concentrations of biocompatible, silica-based, micrometer-sized iron oxide-containing particles (sMPIOs; 40-160 particles/cell). Primary human hepatocytes were incubated with 100 sMPIOs/cell. The particle-labeled cells and the native cells were imaged using a clinical 3.0 T MRI system, whereas the control groups of the labeled and unlabeled cells were kept at room temperature without exposure to a magnetic field. Viability, formation of reactive oxygen species (ROS), aspartate aminotransferase leakage, and urea and albumin synthesis were assessed for a culture period of 5 days.

RESULTS:

The dose finding study showed no adverse effects of the sMPIOs labeling on HuH7 cells. MRI had no adverse effects on the morphology of the sMPIO-labeled primary human hepatocytes. Imaging using the T1- and T2-weighted sequences did not affect the viability, transaminase leakage, formation of ROS, or metabolic activity of the sMPIO-labeled cells or the unlabeled, primary human hepatocytes.

CONCLUSION:

sMPIOs did not induce adverse effects on the labeled cells under the conditions of the magnetic field of a clinical MRI system.

KEYWORDS:

adverse effects; magnetic resonance imaging; sMPIO

PMID:
28537490
DOI:
10.1089/ten.TEC.2017.0118
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center